Bharat Biotech debunks 'political pressure' claims

Bharat Biotech debunks 'political pressure' claims

Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'

FPJ Web DeskUpdated: Thursday, November 17, 2022, 01:55 PM IST
article-image
Image Source: Wikipedia (Representative)

Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'

A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).

According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.

THIS IS A BREAKING STORY. UPDATES SOON

RECENT STORIES

Reliance Shares Jump Nearly 4 Per Cent Post-Q2 Earnings; Market Valuation Surges By ₹67,459 Crore

Reliance Shares Jump Nearly 4 Per Cent Post-Q2 Earnings; Market Valuation Surges By ₹67,459 Crore

Elon Musk Extends Diwali Greetings As Tesla Expands In India Amid $500 Billion Net Worth Milestone

Elon Musk Extends Diwali Greetings As Tesla Expands In India Amid $500 Billion Net Worth Milestone

India Rapidly Emerging As Global Hub For Services Exports: NSE

India Rapidly Emerging As Global Hub For Services Exports: NSE

Bank Nifty Hits Record High On Strong Q2 Show By Private Lenders

Bank Nifty Hits Record High On Strong Q2 Show By Private Lenders

US Tariffs To Drive $1.2 Trillion Surge In Corporate Spending: S&P Global Report

US Tariffs To Drive $1.2 Trillion Surge In Corporate Spending: S&P Global Report